SML1709
K6PC-5
≥98% (HPLC)
别名:
2-己基-N- [2-羟基-1-（羟甲基）乙基] -3-氧代-癸酰胺, K 6PC5;, N-（1,3-二羟丙基）-2-己基-3-氧代癸酰胺
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式（希尔记法）:
C19H37NO4
化学文摘社编号:
分子量:
343.50
UNSPSC Code:
12352200
PubChem Substance ID:
NACRES:
NA.77
Quality Level
assay
≥98% (HPLC)
form
powder
color
white to beige
solubility
DMSO: 20 mg/mL, clear
storage temp.
−20°C
SMILES string
O=C(CCCCCCC)C(CCCCCC)C(NC(CO)CO)=O
InChI key
CGYVFCHCRBGGJG-UHFFFAOYSA-N
Biochem/physiol Actions
K6PC-5 是一种有效选择性鞘氨醇激酶 1（SphK1 或 SK1）激活剂。
K6PC-5 是一种有效选择性鞘氨醇激酶 1（SphK1 或 SK1）激活剂，可在体外培养的正常人表皮角质形成细胞中增加角蛋白 1 和外皮蛋白的表达。K6PC-5 通过胞内 Ca2+ 信号传导促进角质形成细胞的分化和增殖。
signalword
Warning
hcodes
Hazard Classifications
Eye Irrit. 2
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Michaela T Reichmann et al.
The Journal of clinical investigation, 131(15) (2021-06-16)
Tuberculosis (TB) is a persistent global pandemic, and standard treatment for it has not changed for 30 years. Mycobacterium tuberculosis (Mtb) has undergone prolonged coevolution with humans, and patients can control Mtb even after extensive infection, demonstrating the fine balance
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| SML1709-5MG | 04061832274348 |
| SML1709-25MG | 04061832274331 |